Maya Hrachova is a Neurology physician affiliated with Allina Health. OpenAlex indexes 34 publications with 395 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 E 28th St
Minneapolis, MN 554073723
Telephone
612-863-3200Provider last certified this registry record 21 May 2024.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year20251 payment
- JAZZ PHARMACEUTICALS INC.Program year20251 payment
- Novocure Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
51.5%Corticosteroid51.5%Dexamethasone100%Part D≥12 patientsNervous system
30.3%Other antiepileptics30.3%Levetiracetam100%Part D≥12 patientsMetabolism & gastrointestinal
18.2%Serotonin-3 Receptor Antagonist18.2%Ondansetron Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The concept, intention, and evaluation of the term treatment-refractory meningioma
Journal of Neuro-Oncology
2025 - <i>FGFR1</i> fusions in genomically and epigenetically bona fide glioblastoma, IDH-wildtype
Journal of Neuropathology & Experimental Neurology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Joleen Hubbard, MD
Allina Health
Frank Rhame, MD
Allina Health
Brian Swiglo, MD
Allina Health
Craig Strauss, MD, MPH
Allina Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”